We thus evaluated the expression of IL-17B and IL-17RB by real-time quantitative PCR in biopsies from a cohort of patients with breast cancer (n = 143) (Supplementary Table 1) and 10 years of follow-up. This evidence concerns the gene IL17RB and breast carcinoma.